Cellectis Reports 1st Quarter 2018 Financial Results

Financial Gain (Loss): The financial loss was de minimis … By capitalizing on its 18 years of expertise in gene editing – built on its flagship TALEN® technology and pioneering electroporation system PulseAgile – Cellectis uses the power of the …Powered by...